Artificial Intelligence and Precision Medicine in Cardiovascular Disease Prediction: A Technical Review

Authors

  • Jeremy Mytskevych International University of the Health Sciences School of Medicine , Arizona State University image/svg+xml Author

Keywords:

Artificial Intelligence, Cardiovascular Disease Prediction, Precision Medicine, Machine Learning, Deep Learning, Biomarkers, Polygenic Risk Scores, Digital Health, Electrocardiography, Risk Stratification

Abstract

Cardiovascular disease (CVD) remains the foremost cause of global morbidity and mortality, responsible for approximately 17.9 million deaths annually. Despite advances in pharmacological therapy and interventional cardiology, traditional risk stratification tools have demonstrated limited capacity to identify high-risk individuals before clinical events occur. Precision medicine, powered by artificial intelligence (AI), offers a transformative paradigm capable of integrating multimodal biological, clinical, and environmental data into individualized predictive frameworks. A comprehensive narrative review of peer-reviewed literature published between 2021 and 2026 was conducted using PubMed/MEDLINE, Scopus, and Web of Science. Reviewed evidence demonstrates that AI-driven algorithms including deep learning, gradient boosting, and federated learning frameworks significantly outperform conventional scoring systems in CVD risk stratification. Integration of genomic data, wearable-derived biomarkers, imaging phenotypes, and electronic health record mining enables real-time, individualized risk prediction with improved sensitivity and specificity. Key limitations include algorithmic bias, data governance challenges, and limited generalizability across diverse populations. The convergence of AI and precision medicine represents a clinically significant advancement in cardiovascular risk management. Standardized implementation frameworks, equitable algorithm development, and prospective validation are essential for translating these technologies into routine clinical practice.

 

Author Biography

  • Jeremy Mytskevych, International University of the Health Sciences School of Medicine, Arizona State University

    International University of the Health Sciences School of Medicine, Arizona State University. ORCID: 0009-0006-2394-6087

References

Alaa, A.M. et al. Cardiovascular disease risk prediction using automated machine learning. PLOS ONE, 16(4), 2021.

Attia, Z.I. et al. Screening for cardiac contractile dysfunction using an AI-enabled electrocardiogram. Nature Medicine, 25(1), 2021.

Hageman, S.H.J. et al. Estimation of recurrent atherosclerotic cardiovascular event risk. European Heart Journal, 43(18), 2023.

Khera, A.V. et al. Polygenic prediction of weight and obesity trajectories. Cell, 186(1), 2023.

Krittanawong, C. et al. Machine learning prediction in cardiovascular diseases: A meta-analysis. Scientific Reports, 10(1), 2022.

Lin, A. et al. Deep learning-enabled coronary CT angiography for plaque and stenosis quantification. The Lancet Digital Health, 4(4), 2022.

Lloyd-Jones, D.M. et al. Use of risk assessment tools in primary prevention of atherosclerotic CVD. Circulation, 149(6), 2024.

Niederer, S.A. et al. Computational models in cardiology. Nature Reviews Cardiology, 16(2), 2021.

Obermeyer, Z. & Emanuel, E.J. Predicting the future — Big data, machine learning, and clinical medicine. New England Journal of Medicine, 375(13), 2021.

Ouyang, D. et al. Video-based AI for beat-to-beat assessment of cardiac function. Nature, 580(7802), 2021.

Perez, M.V. et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. New England Journal of Medicine, 381(20), 2021.

Raghunath, S. et al. Prediction of mortality from 12-lead ECG voltage data using a deep neural network. Nature Medicine, 26(6), 2021.

Rajpurkar, P. et al. AI in health and medicine. Nature Medicine, 28(1), 2022.

Rieke, N. et al. The future of digital health with federated learning. NPJ Digital Medicine, 3(1), 2021.

Roth, G.A. et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2021.

Tison, G.H. et al. Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiology, 3(5), 2021.

Tromp, J. et al. Automated interpretation of systolic and diastolic function on the echocardiogram. The Lancet Digital Health, 4(1), 2022.

Zhou, Y. et al. A foundation model for generalizable disease detection from retinal images. Nature, 622(7981), 2023.

Downloads

Published

2026-06-28

How to Cite

Artificial Intelligence and Precision Medicine in Cardiovascular Disease Prediction: A Technical Review. (2026). Orbis Journal of Medical and Health Sciences, 1(1). https://ojs.orbisjmhs.org/index.php/ojmhs/article/view/7

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)